調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

ゲノム編集/ゲノム工学の世界市場予測（～2021年）：細胞株工学、動物遺伝子工学、植物遺伝子工学

◆タイトル：Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021
◆商品コード：MAM-BT-3380
◆調査・発行会社：MarketsandMarkets
◆発行日：2016年10月10日
◆ページ数：164
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥0	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥0	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥0	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ゲノム編集/ゲノム工学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、用途別分析、需要先別分析、地域別分析、ゲノム編集/ゲノム工学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The genome editing market is projected to reach USD 5.54 Billion by 2021 from USD 2.84 Billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). Owing to factors such as high prevalence rate of infectious diseases and cancer among patients, technological advancements, rising government funding and growth in the number of genomics projects, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing.
The global genome editing market is segmented on the basis of technology, application end user. By technology, the market is categorized into RISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, and Jump-In). The CRISPR segment is projected to command the largest share of the global market. This segment is also expected to grow at the highest growth rate in the forecast period. The large market share and high growth rate of CRISPR technology segment can be attributed to the ease of use associated with the technology and reduction in off-target effect of CRISPR.

By application, the global genome editing market is categorized into cell line engineering, plant genetic engineering, animal genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is projected to have the highest growth rate in 2016-2021. This segment account for the largest share of the global market in 2016. . Factors such as such as growing industry focus on stem cell research and increasing global awareness about stem cell therapies through various organizations and increasing funding from governments and private organizations are driving the growth of the cell line engineering applications segment.

By end user, the global genome editing market is categorized into biotechnology and pharmaceutical companies, academic & government research institutes, and CORs. The segment projected to account for the largest share of the global end user market in 2016 is biotechnology and pharmaceutical companies. This segment is also projected to have the highest growth rate in the forecast period. The large market share and high growth rate of this segment is attributed to factors such as rapidly increasing aging population and growing prevalence of infectious diseases and cancer.

By region, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to account for the largest share as well as the highest growth rate in the forecast period of the genome editing market, followed by Europe and Asia-Pacific. Owing to factors such as increasing use of GM crops; prevalence of Alzheimer’s disease, dementia, infectious diseases, and cancer in the U.S. development of gene therapy in the U.S.; growing availability of research grants and funding, and genome editing standards workshops and conferences are likely to propel the market in North America.

The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This segment is also projected to have the highest growth rate in the forecast period.

The prominent players in the global genome editing market were Thermo Fisher Scientific, Inc. (U.S.), Merck KGAA (Germany), and Horizon Discovery Group Plc (U.K.) in 2015. These companies are dominant in the market mainly due to their well-established presence in the field of genomics, presence in over 50 countries, high R&D investments, and strong sales and distribution force. While the other players includes, Genscript Biotech Corporation (U.S.), Sangamo Biosciences, Inc. (U.S.), Integrated DNA Technologies, Inc (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.3.1 Market Data Validation and Triangulation
2.3.2 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Genome Editing: Market Overview
4.2 Geographic Analysis: Genome Editing Market, By Application (2016)
4.3 Market Size, By Technology, 2016 vs 2021
4.4 Market Size, By Application, 2016 vs 2021
4.5 Market Size, By End User, 2016 vs 2021
4.6 Geographical Snapshot of the Genome Editing Market

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 High Prevalence Rate of Infectious Diseases and Cancer Among Patients
5.2.1.3 Technological Advancements
5.2.1.4 Increase in Demand for Synthetic Genes
5.2.1.5 Rise in Production of Genetically Modified Crops
5.2.1.6 Increasing Awareness About Genomics
5.2.1.7 New Product Launches By Industry Players
5.2.2 Restraints
5.2.2.1 High Cost of Genomic Equipment
5.2.2.2 Adverse Public Perception Related to Genetic Research
5.2.3 Opportunities
5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
5.2.3.2 Emerging Markets in Developing Countries
5.2.4 Challenges
5.2.4.1 Off-Target Effect of CRISPR
5.2.4.2 Shortage of Trained Professionals

6 Global Genome Editing/Engineering Market, By Technology (Page No. – 48)
6.1 Introduction
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 Antisense
6.6 Other Technologies

7 Global Genome Editing/Genome Engineering Market, By Application (Page No. – 61)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Animal Genetic Engineering
7.4 Plant Genetic Engineering
7.5 Other Applications

8 Global Genome Editing/Engineering Market, By End User (Page No. – 73)
8.1 Introduction
8.2 Biotechnology & Pharmaceutical Companies
8.3 Academic & Government Research Institutes
8.4 Contract Research Organizations

9 Genome Editing/Genome Engineering Market, By Region (Page No. – 81)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Development of Gene Therapy in the U.S.
9.2.1.2 Increasing Use of Gm Crops
9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States
9.2.1.4 Genome Editing Conferences in the U.S.
9.2.1.5 Rising Availability of Research Grants and Funding
9.2.1.6 Genome Editing Standards Workshop in the U.S.
9.2.1.7 Increasing Prevalence of Cancer
9.2.1.8 Strategic Developments in the U.S. Market
9.2.2 Canada
9.2.2.1 Availability of Research Funding in Canada
9.2.2.2 Rising Incidence of Cancer
9.2.2.3 Gapp to Intensify Genomic R&D
9.3 Europe
9.3.1 Conferences and Meetings in Europe
9.3.2 U.K.
9.3.2.1 Increased Funds, and Grants By Government Bodies
9.3.2.2 100,000 Genomes Project in U.K.
9.3.3 Germany
9.3.3.1 Availability of Funding for Life Science Research
9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany
9.3.3.3 RoE
9.3.3.4 Spain’s Focus on Research
9.3.3.5 Growth in the Italian Biotech and Pharma Sectors
9.3.3.6 Growing Research Investments in Sweden & Denmark
9.4 Asia-Pacific
9.4.1 China
9.4.1.1 High Intensity of R&D Activities in China
9.4.1.2 Growing Focus of Global Companies on China
9.4.2 Japan
9.4.2.1 Involvement of Industry Players in the Japanese Market: Significant Developments
9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
9.4.2.3 Focus on Cancer Research and Treatment
9.4.3 India
9.4.3.1 Emergence of Local Players in India
9.4.3.2 Growth of the Pharmaceutical Industry in India
9.4.3.3 Development of Bio-Clusters to Boost India’s Biotechnology Industry
9.4.4 RoAPAC
9.4.4.1 Australia: Availability of Financial Support for Research
9.4.4.2 Genome Asia 100k Initiative
9.4.4.3 Crop Research Initiatives in Asia
9.5 RoW
9.5.1 Genetic Testing and Genomic Analysis in the Middle East
9.5.2 Brazil: Investments in Research and Innovation Centers and Conferences & Workshops
9.5.3 Rising Prevalence of Hiv, Cancer in Africa

10 Competitive Landscape (Page No. – 119)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Introduction
10.2.2 Thermo Fisher Scientific, Inc.
10.2.3 Merck KGaA
10.2.4 Horizon Discovery Group PLC
10.3 Competitive Situation and Trends
10.3.1 Agreements, Collaborations, and Partnerships
10.3.2 Product & Service Launches
10.3.3 Acquisitions
10.3.4 Expansions
10.3.5 Other Strategies
10.4 Strategic Benchmarking

11 Company Profiles (Page No. – 131)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Horizon Discovery Group PLC
11.4 Genscript USA Inc.
11.5 Sangamo Biosciences, Inc.
11.6 Integrated DNA Technologies, Inc.
11.7 Lonza Group Ltd.
11.8 New England Biolabs, Inc.
11.9 Origene Technologies, Inc.
11.10 Transposagen Biopharmaceuticals, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 152)
12.1 Discussion Guide
12.2 Other Developments, By Company (2013–2016)
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables (105 Tables)

Table 1 Global Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 2 CRISPR-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 3 North America: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 4 Europe: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 5 Asia-Pacific: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 6 TALEN-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 7 North America: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 8 Europe: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 9 Asia-Pacific: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 10 ZFN-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 11 North America: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 12 Europe: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 13 Asia-Pacific: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 14 Antisense Technology-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 15 North America: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 16 Europe: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 17 Asia-Pacific: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 18 Other Genome Editing Technologies Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 23 Market Size for Cell Line Engineering, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size for Cell Line Engineering, By Country, 2014–2021 (USD Million)
Table 25 Europe: Market Size for Cell Line Engineering, By Country/Region, 2014–2021 (USD Million)
Table 26 Asia-Pacific: Market Size for Cell Line Engineering, By Country/Region, 2014–2021 (USD Million)
Table 27 Market Size for Animal Genetic Engineering, By Region, 2014–2021 (USD Million)
Table 28 North America: Market Size for Animal Genetic Engineering, By Country, 2014–2021 (USD Million)
Table 29 Europe: Market Size for Animal Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 30 Asia-Pacific: Market Size for Animal Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 31 Market Size for Plant Genetic Engineering, By Region, 2014–2021 (USD Million)
Table 32 North America: Market Size for Plant Genetic Engineering, By Country, 2014–2021 (USD Million)
Table 33 Europe: Market Size for Plant Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 34 Asia-Pacific: Market Size for Plant Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 35 Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 36 North America: Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 37 Europe: Market Size for Other Applications, By Country/Region, 2014–2021 (USD Million)
Table 38 Asia-Pacific: Market Size for Other Applications, By Country/Region, 2014–2021 (USD Million)
Table 39 Global Market Size, By End User, 2014–2021 (USD Million)
Table 40 Market Size for Biotechnology and Pharmaceutical Companies, By Region, 2014–2021 (USD Million)
Table 41 North America: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 42 Europe: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 43 Asia-Pacific: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 44 Market Size for Academic & Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 45 North America: Market Size for Academic & Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 46 Europe: Market Size for Academic & Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 47 Asia-Pacific: Market Size for Academic & Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 48 Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 50 Europe: Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 51 Asia-Pacific: Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 52 Market Size, By Region, 2014–2021 (USD Million)
Table 53 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 54 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 55 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 56 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 57 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 58 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 59 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 60 Indicative List of Projects Funded By GAPP in 2014
Table 61 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 62 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 63 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 64 Prominent Events in Europe
Table 65 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 66 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 67 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 68 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 69 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 70 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 71 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 72 Events in Germany
Table 73 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 75 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 76 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 77 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 78 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 83 China: Market Size, By Technology, 2014–2021 (USD Million)
Table 84 China: Market Size, By Application, 2014–2021 (USD Million)
Table 85 China: Market Size, By End User, 2014–2021 (USD Million)
Table 86 Conferences, Symposia, & Workshops in Japan (2016)
Table 87 Japan: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 88 Japan: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 89 Japan: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 90 India: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 91 India: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 92 India: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 93 RoAPAC: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 94 RoAPAC: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 95 RoAPAC: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 96 Hiv Infections and Aids-Related Deaths in the Middle East and Africa, 2014
Table 97 RoW: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 98 RoW: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 99 RoW: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 100 Agreements, Collaborations, and Partnerships (2013–2016)
Table 101 Product & Service Launches (2013–2016)
Table 102 Acquisitions (2013–2016)
Table 103 Expansions (2013–2016)
Table 104 Other Strategies (2013–2016)
Table 105 Market Developments Between 2013 & 2016

List of Figures (45 Figures)

Figure 1 Global Genome Editing Market Segmentation
Figure 2 Global Genome Editing Market: Research Methodology
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Global Genome Editing Market Analysis, By Technology (2016-2021)
Figure 9 Global Genome Editing Market Analysis, By Application, 2016 vs 2021
Figure 10 Global Genome Editing Market Analysis, By End User, 2016 vs 2021
Figure 11 Global Genome Editing Market, By Region, 2016 – 2021
Figure 12 Genome Editing Market Projected to Witness A Double-Digit Growth Rate in the Forecast Period
Figure 13 Cell Line Engineering Segment to Dominate the Genome Editing Market in 2016
Figure 14 CRISPR Segment to Witness the Highest Growth Rate During Forecast Period
Figure 15 Cell Line Engineering Segment to Grow at the Highest CAGR During the Forecast Period
Figure 16 Biotechnology & Pharmaceutical Companies to Command the Largest Market Share in 2016
Figure 17 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 18 Drivers, Restraints, Opportunities, Challenges, and Trends
Figure 19 Global Genome Editing Market, By Technology, 2016 vs 2021
Figure 20 North America is Estimated to Account for the Largest Share of CRISPR-Based Genome Editing Market
Figure 21 Global Genome Editing Market Size, By Application, 2016 vs 2021
Figure 22 North America is Estimated to Account for the Largest Share of the Cell Line Engineering Market
Figure 23 Genome Editing Market, By End User (2016 vs 2021)
Figure 24 Genome Editing Market, By Region, 2016 vs 2021
Figure 25 North America: Genome Editing Market Snapshot
Figure 26 Prevalence of Alzheimer's Disease in U.S., 2015.
Figure 27 Europe: Genome Editing Market Snapshot
Figure 28 Asia-Pacific: Genome Editing Market Snapshot
Figure 29 RoW: Genome Editing Market Snapshot
Figure 30 Agreements, Partnerships and Collaborations are the Major Strategies Adopted By the Key Players, 2013–2016
Figure 31 Market Share Analysis, By Key Player (2015)
Figure 32 Agreements, Collaborations, and Partnerships Key Growth Strategy Adopted By Market Players
Figure 33 Agreements, Collaborations, and Partnerships, By Company (2013–2016)
Figure 34 Product & Service Launches, By Company (2013–2016)
Figure 35 Acquisitions, By Company (2013–2016)
Figure 36 Expansions, By Company (2013–2016)
Figure 37 Other Strategies, By Company (2013–2016)
Figure 38 Geographic Revenue Mix of Market Players
Figure 39 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 40 Merck KGaA: Company Snapshot
Figure 41 Sigma-Aldrich Corporation: Company Snapshot
Figure 42 Horizon Discovery Group PLC: Company Snapshot
Figure 43 Genscript USA Inc.: Company Snapshot
Figure 44 Sangamo Biosciences, Inc.: Company Snapshot
Figure 45 Lonza Group Ltd.: Company Snapshot

【レポートのキーワード】

ゲノム編集、ゲノム工学、ゲノム技術、CRISPR、TALEN、ZFN、細胞株工学、動物遺伝子工学、植物遺伝子工学、バイオ技術、製薬、医薬品

★調査レポート[ゲノム編集/ゲノム工学の世界市場予測（～2021年）：細胞株工学、動物遺伝子工学、植物遺伝子工学] ( Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021 / MAM-BT-3380) 販売に関する免責事項

[ゲノム編集/ゲノム工学の世界市場予測（～2021年）：細胞株工学、動物遺伝子工学、植物遺伝子工学] ( Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021 / MAM-BT-3380) についてEメールでお問い合わせ

◆H&Iグローバルリサーチ株式会社のお客様（例）◆